VERV
Verve Therapeutics
VERV
VERV
Delisted
VERV was delisted on the 24th of July, 2025.
123 hedge funds and large institutions have $1.21B invested in Verve Therapeutics in 2022 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 47 increasing their positions, 29 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 125 → 123 (-2)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
42% less capital invested
Capital invested by funds: $2.08B → $1.21B (-$871M)
Holders
123
Holding in Top 10
4
Calls
$9M
Puts
$1.15M
Top Buyers
| 1 | +$44.3M | |
| 2 | +$25.8M | |
| 3 | +$14.4M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$13.8M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$12M |
Top Sellers
| 1 | -$26.6M | |
| 2 | -$25.8M | |
| 3 | -$25.2M | |
| 4 |
CC
Casdin Capital
New York
|
-$23.5M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.3M |